{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T14:16:55Z","timestamp":1771597015436,"version":"3.50.1"},"reference-count":28,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["bjoms.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["British Journal of Oral and Maxillofacial Surgery"],"published-print":{"date-parts":[[2022,5]]},"DOI":"10.1016\/j.bjoms.2021.07.019","type":"journal-article","created":{"date-parts":[[2021,8,5]],"date-time":"2021-08-05T11:27:16Z","timestamp":1628162836000},"page":"459-464","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Patients' experience and perceived concerns regarding obtaining and taking prescriptions for head and neck osteoradionecrosis"],"prefix":"10.1016","volume":"60","author":[{"given":"Edward J.","family":"Willcocks","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yvonne B.Y.","family":"Lim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simon N.","family":"Rogers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.bjoms.2021.07.019_b0005","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1111\/idj.12318","article-title":"Osteoradionecrosis of the jaws: definition, epidemiology, staging and clinical and radiological findings","volume":"68","author":"Chronopoulos","year":"2018","journal-title":"A concise review. Int Dent J."},{"issue":"9","key":"10.1016\/j.bjoms.2021.07.019_b0010","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1016\/j.bjoms.2015.07.008","article-title":"Longitudinal evaluation of health-related quality of life after osteoradionecrosis of the mandible","volume":"53","author":"Rogers","year":"2015","journal-title":"Br J Oral Maxillofac Surg."},{"key":"10.1016\/j.bjoms.2021.07.019_b0015","doi-asserted-by":"crossref","unstructured":"Yang DZ, F.; Fu, X.; Hou, J.; Lin, L.; Huang, Q.; Yeh, C. H. Symptom distress and interference among cancer patients with osteoradionecrosis of jaw: A cross-sectional study. International Journal of Nursing Sciences. 2019;6(3):278-82.","DOI":"10.1016\/j.ijnss.2019.05.006"},{"key":"10.1016\/j.bjoms.2021.07.019_b0020","doi-asserted-by":"crossref","unstructured":"Chieng CYD, A.; Aziz, A.; Lowe, D.; Rogers, S. N. Health related quality of life and patient concerns with osteoradionecrosis. British Journal of Oral & Maxillofacial Surgery. 2021;In Print","DOI":"10.1016\/j.bjoms.2021.02.011"},{"issue":"9","key":"10.1016\/j.bjoms.2021.07.019_b0025","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1038\/bjc.2016.304","article-title":"Cancer incidence and mortality projections in the UK until 2035","volume":"115","author":"Smittenaar","year":"2016","journal-title":"Br J Cancer."},{"issue":"22","key":"10.1016\/j.bjoms.2021.07.019_b0030","doi-asserted-by":"crossref","first-page":"6598","DOI":"10.1158\/0008-5472.CAN-16-0633","article-title":"HPV-Related Oropharynx Cancer in the United Kingdom: An Evolution in the Understanding of Disease Etiology","volume":"76","author":"Schache","year":"2016","journal-title":"Cancer Res."},{"issue":"2","key":"10.1016\/j.bjoms.2021.07.019_b0035","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1002\/hed.20121","article-title":"Major healing of refractory mandible osteoradionecrosis after treatment combining pentoxifylline and tocopherol: a phase II trial","volume":"27","author":"Delanian","year":"2005","journal-title":"Head Neck."},{"issue":"2","key":"10.1016\/j.bjoms.2021.07.019_b0040","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.radonc.2004.08.021","article-title":"The radiation-induced fibroatrophic process: therapeutic perspective via the antioxidant pathway","volume":"73","author":"Delanian","year":"2004","journal-title":"Radiotherapy and Oncology."},{"issue":"3","key":"10.1016\/j.bjoms.2021.07.019_b0045","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1016\/j.ijrobp.2010.03.029","article-title":"Complete restoration of refractory mandibular osteoradionecrosis by prolonged treatment with a pentoxifylline-tocopherol-clodronate combination (PENTOCLO): a phase II trial","volume":"80","author":"Delanian","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys."},{"issue":"5","key":"10.1016\/j.bjoms.2021.07.019_b0050","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.oooo.2018.02.004","article-title":"Pentoxifylline, tocopherol, and clodronate for the treatment of mandibular osteoradionecrosis: a systematic review","volume":"125","author":"Martos-Fernandez","year":"2018","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol."},{"issue":"2","key":"10.1016\/j.bjoms.2021.07.019_b0055","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.ijom.2018.08.007","article-title":"Management of osteoradionecrosis of the jaws with pentoxifylline-tocopherol: a systematic review of the literature and meta-analysis","volume":"48","author":"Kolokythas","year":"2019","journal-title":"Int J Oral Maxillofac Surg."},{"issue":"14","key":"10.1016\/j.bjoms.2021.07.019_b0060","doi-asserted-by":"crossref","first-page":"2488","DOI":"10.1016\/j.ejca.2009.05.015","article-title":"Pentoxifylline and vitamin E treatment for prevention of radiation-induced side-effects in women with breast cancer: a phase two, double-blind, placebo-controlled randomised clinical trial (Ptx-5)","volume":"45","author":"Magnusson","year":"2009","journal-title":"Eur J Cancer."},{"issue":"5","key":"10.1016\/j.bjoms.2021.07.019_b0065","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.bjoms.2016.02.024","article-title":"Prophylactic use of pentoxifylline and tocopherol in patients who require dental extractions after radiotherapy for cancer of the head and neck","volume":"54","author":"Patel","year":"2016","journal-title":"Br J Oral Maxillofac Surg."},{"issue":"2","key":"10.1016\/j.bjoms.2021.07.019_b0070","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.coms.2014.02.002","article-title":"Pharmacologic modalities in the treatment of osteoradionecrosis of the jaw","volume":"26","author":"McCaul","year":"2014","journal-title":"Oral Maxillofac Surg Clin North Am."},{"issue":"3","key":"10.1016\/j.bjoms.2021.07.019_b0075","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1111\/ors.12337","article-title":"Patient-reported side effects from liquid formulation of pentoxifylline and tocopherol in head and neck radiotherapy patients: an institutional experience and retrospective analysis","volume":"11","author":"Patel","year":"2018","journal-title":"Oral Surgery."},{"issue":"1","key":"10.1016\/j.bjoms.2021.07.019_b0080","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.bjoms.2010.11.017","article-title":"Pentoxifylline and tocopherol in the management of patients with osteoradionecrosis, the Portsmouth experience","volume":"50","author":"McLeod","year":"2012","journal-title":"Br J Oral Maxillofac Surg."},{"issue":"3","key":"10.1016\/j.bjoms.2021.07.019_b0085","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1002\/hed.10171","article-title":"Management of mandibular osteoradionecrosis corresponding to the severity of osteoradionecrosis and the method of radiotherapy","volume":"25","author":"Notani","year":"2003","journal-title":"Head Neck."},{"key":"10.1016\/j.bjoms.2021.07.019_b0090","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1186\/s12909-016-0663-8","article-title":"Current training provision and training needs in oral health for UK general practice trainees: survey of General Practitioner Training Programme Directors","volume":"16","author":"Ahluwalia","year":"2016","journal-title":"BMC Med Educ."},{"key":"10.1016\/j.bjoms.2021.07.019_b0095","doi-asserted-by":"crossref","unstructured":"Carter LM, Ogden GR. Oral cancer awareness of general medical and general dental practitioners. Br Dent J. 2007;203(5):E10; discussion 248-9.","DOI":"10.1038\/bdj.2007.630"},{"issue":"11","key":"10.1016\/j.bjoms.2021.07.019_b0100","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/j.clon.2014.08.009","article-title":"Persistent dysphagia after head and neck radiotherapy: a common and under-reported complication with significant effect on non-cancer-related mortality","volume":"26","author":"Szczesniak","year":"2014","journal-title":"Clin Oncol (R Coll Radiol)."},{"key":"10.1016\/j.bjoms.2021.07.019_b0105","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.oraloncology.2017.12.021","article-title":"Late radiation-associated dysphagia in head and neck cancer patients: evidence, research and management","volume":"77","author":"De Felice","year":"2018","journal-title":"Oral Oncol."},{"issue":"23","key":"10.1016\/j.bjoms.2021.07.019_b0110","doi-asserted-by":"crossref","first-page":"5793","DOI":"10.1002\/cncr.27631","article-title":"Late dysphagia after radiotherapy-based treatment of head and neck cancer","volume":"118","author":"Hutcheson","year":"2012","journal-title":"Cancer."},{"key":"10.1016\/j.bjoms.2021.07.019_b0115","doi-asserted-by":"crossref","unstructured":"Cleary JDE, P. C.; Hikal, A. H.; Chapman, S. W. Administration of crushed extended-release pentoxifylline tablets: bioavailability and adverse effects. Am J Health-Syst Pharm. 1999;56:1519-34.","DOI":"10.1093\/ajhp\/56.15.1529"},{"key":"10.1016\/j.bjoms.2021.07.019_b0120","doi-asserted-by":"crossref","unstructured":"Dissard A, N PD, Barthelemy I, Delbet C, Puechmaille M, Depeyre A, et al. Efficacy of pentoxifylline-tocopherol-clodronate in mandibular osteoradionecrosis. Laryngoscope. 2019;130(11):E559-E66.","DOI":"10.1002\/lary.28399"},{"issue":"1","key":"10.1016\/j.bjoms.2021.07.019_b0125","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.adro.2017.09.004","article-title":"Pentoxifylline and vitamin E drug compliance after adjuvant breast radiation therapy","volume":"3","author":"Famoso","year":"2018","journal-title":"Adv Radiat Oncol."},{"key":"10.1016\/j.bjoms.2021.07.019_b0130","unstructured":"medicines.org.uk. Summary of Product Characteristics - Trental 400mg Modified Release Tablets [updated 16\/08\/2019. Available from: https:\/\/www.medicines.org.uk\/emc\/product\/909\/smpc#gref."},{"key":"10.1016\/j.bjoms.2021.07.019_b0135","unstructured":"medicines.org.uk. Summary of Product Characteristics - Vitamin E Suspension 100mg\/ml [updated 05\/09\/2016. Available from: https:\/\/www.medicines.org.uk\/emc\/product\/3734\/smpc#gref."},{"key":"10.1016\/j.bjoms.2021.07.019_b0140","unstructured":"medicines.org.uk. Summary of Product Characteristics - Doxycycline 100mg Capsules [updated 05\/02\/2021. Available from: https:\/\/www.medicines.org.uk\/emc\/product\/4063\/smpc#gref."}],"container-title":["British Journal of Oral and Maxillofacial Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0266435621002990?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0266435621002990?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T15:30:10Z","timestamp":1759419010000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0266435621002990"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5]]},"references-count":28,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022,5]]}},"alternative-id":["S0266435621002990"],"URL":"https:\/\/doi.org\/10.1016\/j.bjoms.2021.07.019","relation":{},"ISSN":["0266-4356"],"issn-type":[{"value":"0266-4356","type":"print"}],"subject":[],"published":{"date-parts":[[2022,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Patients' experience and perceived concerns regarding obtaining and taking prescriptions for head and neck osteoradionecrosis","name":"articletitle","label":"Article Title"},{"value":"British Journal of Oral and Maxillofacial Surgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bjoms.2021.07.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The British Association of Oral and Maxillofacial Surgeons. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}